Indiana University
Colorectal Cancer Studies Show Promise of Blood-, Stool-Based Screening
Research teams explored the performance of circulating cell-free DNA and stool DNA testing to find colorectal cancer in average-risk individuals.
The test detects blood gene expression biomarkers that are predictive of high hallucination and high delusion states and future hospitalizations.
Presence of cfDNA, CTCs Predicts Recurrence in Triple-Negative Breast Cancer
Analyzing both circulating tumor DNA and circulating tumor cells, investigators could classify patients into groups with significantly higher and lower recurrence risk.
Foundation Medicine's ctDNA assay was able to subclassify patients into higher and lower recurrence risk groups with CTCs providing an additional boost.
In a study involving 250 military veterans, researchers have reported identifying and testing gene expression biomarkers whose levels rise with human stress.